Cancer Antigen (CA) 125

Discover the latest on Medi Linx Laboratory

KNOW OUR DIRECTORY OF SERVICES

Explore our comprehensive test menu covering a wide range of medical specialties to support accurate diagnoses and patient management. From routine chemistry to advanced genomics—we’ve got you covered.

Cancer Antigen (CA) 125

Test Information:
This assay is indicated for use as an aid in the detection of residual or recurrent ovarian carcinoma in patients who have undergone first‑line therapy and would be considered for second-look procedures. This assay is further indicated for serial measurement of CA 125 to aid in the management of cancer patients. This assay is also intended to be used in conjunction with the HE4 assay as part of ROMA (Risk Of Ovarian Malignancy Algorithm) for the risk assessment of ovarian cancer in pre- and postmenopausal women presenting with pelvic mass.

Specimen Container:
Gold Top SST Tube (with clot activator) or Red Top Tube (Plain) – USE PLASTIC TUBE

Specimen Type:
Serum

Required Volume:
2 mL

Patient Preparation:
No Patient Preparation

Notes:
N/A (Not Applicable)

Storage & Stability
(Before Processing)

  • Storage: 2 to 8°C
    Stability: 5 days
  • Storage: 20 to 25°C
    Stability: 8 hours
  • Storage: – 20°C
    Stability: 24 weeks

FREEZE ONLY ONCE!

Transport Temperature:
Ref (2˚C – 8˚C)

Test Category:
Routine

Test Schedule:
Daily

Results Availability:
Within 4 hours

At MEDI LINX LABORATORY INC., we are committed to safeguarding the privacy and security of your personal and health-related information. This data privacy statement outlines how we collect, use, disclose, and protect your data to ensure compliance with applicable laws and regulations, including but not limited to Republic Act No. 10173, its Implementing Rules and Regulations, and the issuance/s set forth by the National Privacy Commission (NPC).

Click here to read the Data Privacy Statement in full.